Arcutis Biotherapeutics (ARQT)
(Delayed Data from NSDQ)
$8.75 USD
+0.01 (0.11%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $8.75 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.65 |
EPS Last Quarter | -0.72 |
Last EPS Surprise | -10.77% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.49 |
Next Year | -1.77 |
EPS (TTM) | -3.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 111.12M | 228.58M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 111.12M | 228.58M |
Low Estimate | NA | NA | 111.12M | 228.58M |
Year ago Sales | 2.78M | 5.19M | 59.61M | 111.12M |
Year over Year Growth Est. | NA | NA | 86.43% | 105.70% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.65 | NA | -2.49 | -1.77 |
# of Estimates | 1 | NA | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.65 | NA | -2.45 | -1.59 |
Low Estimate | -0.65 | NA | -2.53 | -1.95 |
Year ago EPS | -1.31 | -1.16 | -3.78 | -2.49 |
Year over Year Growth Est. | 50.38% | NA | 34.13% | 28.92% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 2 | 1 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.65 | NA | -2.49 | -1.77 |
7 Days Ago | -0.65 | NA | -2.49 | -1.77 |
30 Days Ago | -0.65 | NA | -2.49 | -1.77 |
60 Days Ago | NA | NA | -2.65 | -1.87 |
90 Days Ago | NA | NA | -2.65 | -1.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.65 | NA | -2.49 | -1.77 |
Zacks Consensus Estimate | -0.65 | NA | -2.49 | -1.77 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.72 | -0.73 | -1.16 | -1.31 | NA |
Estimate | -0.65 | -0.90 | -1.22 | -1.30 | NA |
Difference | -0.07 | 0.17 | 0.06 | -0.01 | 0.04 |
Surprise | -10.77% | 18.89% | 4.92% | -0.77% | 3.07% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more